Page 97 - Amgen News Today

WASHINGTON TRUST Co trimmed its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.4% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 48,274 shares of the medical research company’s stock after selling 195 shares during the quarter. WASHINGTON TRUST Co’s holdings in Amgen were worth $13,904,000 at the end […]

In February, the Colorado Prescription Drug Affordability Board ruled the arthritis drug Enbrel was unaffordable for patients in the state. The lawsuit, filed Friday by drugmaker Amgen and two of its subsidiaries, alleged that the board wasn’t only wrong to find Enbrel unaffordable, but that the law that created it was unconstitutional.

The healthcare industry remains a focal point of President Biden's antitrust agenda.

Bouchey Financial Group Ltd grew its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 25.7% during the fourth quarter, HoldingsChannel reports. The firm owned 1,685 shares of the medical research company’s stock after purchasing an additional 344 shares during the quarter. Bouchey Financial Group Ltd’s holdings in Amgen were worth $485,000 as of its […]

Bouchey Financial Group Ltd raised its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 25.7% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,685 shares of the medical research company’s stock after acquiring an additional 344 shares during the period. Bouchey Financial Group Ltd’s […]

Thompson Investment Management Inc. trimmed its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,366 shares of the medical research company’s stock after selling 245 shares during the period. Thompson Investment Management Inc.’s […]

Red Door Wealth Management LLC raised its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,109 shares of the medical research company’s stock after purchasing an […]

RAVE Restaurant Group Appoints CFO and Bolsters Executive Team to Accelerate ...

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched...

RAVE Restaurant Group [NASDAQ: RAVE] today announced a strategic reshaping of its executive team. These appointments represent a significant upgrade to the leadership team, signaling investors and...